80 related articles for article (PubMed ID: 8395706)
1. Soluble thrombomodulin levels during orthotopic liver transplantation.
Riewald M; Himmelreich G; Breindl P; Neuhaus P; Riess H
Semin Thromb Hemost; 1993; 19(3):246-9. PubMed ID: 8395706
[No Abstract] [Full Text] [Related]
2. The "lytic state" during orthotopic liver transplantation: plasminogen activators and other protease activities.
Palareti G; Legnani C; Mazziotti A; Zanello M; Sama C; Coccheri S
Semin Thromb Hemost; 1993; 19(3):290-1. PubMed ID: 8362258
[No Abstract] [Full Text] [Related]
3. [Soluble thrombomodulin: as a marker of endothelial injury].
Maruyama I; Shinmyozu K
Rinsho Byori; 1994 Jun; 42(6):563-8. PubMed ID: 8051797
[TBL] [Abstract][Full Text] [Related]
4. Factor XIII activity during orthotopic liver transplantation.
Himmelreich G; Müller C; Isenberg C; Bechstein WO; Roissant R; Riess H
Semin Thromb Hemost; 1993; 19(3):243-5. PubMed ID: 7689750
[No Abstract] [Full Text] [Related]
5. Plasma thrombomodulin as a marker of endothelium damage.
Boffa MC; Karochkine M; Bérard M
Nouv Rev Fr Hematol (1978); 1991; 33(6):529-30. PubMed ID: 1667951
[TBL] [Abstract][Full Text] [Related]
6. Intraoperative monitoring and postoperative reevaluation of hemostasis in orthotopic liver transplantation.
Azad SC; Kratzer MA; Groh J; Welte M; Haller M; Pratschke E
Semin Thromb Hemost; 1993; 19(3):233-7. PubMed ID: 8362253
[No Abstract] [Full Text] [Related]
7. [Soluble thrombomodulin: a specific parameter of endothelial injury].
Kazama M
Rinsho Ketsueki; 1991 Feb; 32(2):103-7. PubMed ID: 1851235
[TBL] [Abstract][Full Text] [Related]
8. Coagulation and fibrinolysis in orthotopic liver transplantation: current views and insights.
Porte RJ
Semin Thromb Hemost; 1993; 19(3):191-6. PubMed ID: 8362248
[TBL] [Abstract][Full Text] [Related]
9. Hemostasis in heterotopic liver transplantation.
Groenland TH; Porte RJ; Bakker CM; Stibbe J
Semin Thromb Hemost; 1993; 19(3):213-7. PubMed ID: 8362250
[No Abstract] [Full Text] [Related]
10. Serum thrombomodulin as a prognostic marker of disseminated intravascular coagulation.
Kotajima N; Kanda T; Fukumura Y; Kobayashi I
J Med; 1999; 30(1-2):19-29. PubMed ID: 10515237
[TBL] [Abstract][Full Text] [Related]
11. [Molecular markers for the blood coagulation and fibrinolysis].
Okajima K
Rinsho Byori; 2001 Mar; Suppl 115():74-90. PubMed ID: 11391940
[TBL] [Abstract][Full Text] [Related]
12. [Molecular markers of hemostatic mechanisms--clinical significance of the measurement of plasma thrombomodulin].
Ishii H; Uchiyama H; Hiraishi S; Nakano M; Tsubouchi J; Kazama M; Tanaka A
Rinsho Byori; 1989 Mar; 37(3):266-71. PubMed ID: 2545950
[No Abstract] [Full Text] [Related]
13. Systemic fibrinogenolysis in liver transplantation.
Grosse H; Lobbes W; Sato M; Ringe B; Barthels M
Transplant Proc; 1990 Oct; 22(5):2303-4. PubMed ID: 2219380
[No Abstract] [Full Text] [Related]
14. [Evidence of elevated soluble plasma thrombomodulin in atherosclerosis].
Conri C; Seigneur M; Constans J; Mercier P; Baste JC; Dufourcq P; Boisseau MR
J Mal Vasc; 1993; 18(2):112-8. PubMed ID: 8394402
[TBL] [Abstract][Full Text] [Related]
15. [Dynamics of blood coagulation and fibrinolysis and laboratory findings in disseminated intravascular coagulation].
Madoiwa S
Rinsho Ketsueki; 2010 Jan; 51(1):20-8. PubMed ID: 20134136
[No Abstract] [Full Text] [Related]
16. The glycosaminoglycan of recombinant human soluble thrombomodulin affects antithrombotic activity in a rat model of tissue factor-induced disseminated intravascular coagulation.
Nawa K; Itani T; Ono M; Sakano K; Marumoto Y; Iwamoto M
Thromb Haemost; 1992 Mar; 67(3):366-70. PubMed ID: 1322570
[TBL] [Abstract][Full Text] [Related]
17. Serial changes in neutrophil-endothelial activation markers during the course of sepsis associated with disseminated intravascular coagulation.
Gando S; Kameue T; Matsuda N; Hayakawa M; Hoshino H; Kato H
Thromb Res; 2005; 116(2):91-100. PubMed ID: 15907522
[TBL] [Abstract][Full Text] [Related]
18. [Recombinant thrombomodulin].
Maruyama I; Okadome T; Yamamoto S
Rinsho Byori; 1990 Jul; Suppl 86():194-8. PubMed ID: 2172595
[No Abstract] [Full Text] [Related]
19. Low levels of thrombin activatable fibrinolysis inhibitor (TAFI) in patients with chronic liver disease.
Van Thiel DH; George M; Fareed J
Thromb Haemost; 2001 Apr; 85(4):667-70. PubMed ID: 11341503
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the responses of global tests of coagulation with molecular markers of neutrophil, endothelial, and hemostatic system perturbation in the baboon model of E. colisepsis--toward a distinction between uncompensated overt DIC and compensated non-overt DIC.
Wada H; Yamamuro M; Inoue A; Shiku H; Sakuragawa N; Redl H; Peer G; Taylor FB
Thromb Haemost; 2001 Dec; 86(6):1489-94. PubMed ID: 11776318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
